Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPK1 | P28482 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16577201 | 1.00 | MAPK1 (0.41) | MAPK1 | |
| SCHEMBL755226 | 0.85 | MAPK1 (0.48) | MAPK1 | |
| SCHEMBL13759439 | 0.85 | — | — | |
| SCHEMBL19543102 | 0.82 | — | — | |
| SCHEMBL19543111 | 0.81 | MAPK1 (0.34) | MAPK1 | |
| SCHEMBL19543105 | 0.78 | MAPK1 (0.32) | MAPK1 | |
| SCHEMBL17085245 | 0.78 | MAPK1 (0.42) | MAPK1 | |
| SCHEMBL15760607 | 0.78 | MAPK1 (0.42) | MAPK1 | |
| SCHEMBL16368826 | 0.78 | MAPK1 (0.42) | MAPK1 | |
| SCHEMBL20995928 | 0.78 | MAPK1 (0.42) | MAPK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3826985-B1 | DENDRIMER-TYPE COMPOUNDS, METHODS FOR PRODUCING SAME, AND USES THEREOF | UNIV REIMS CHAMPAGNE ARDENNE (FR) | 2022-05-04 | — | — | EP | disclosed |
| WO-2020021034-A1 | DENDRIMER-TYPE COMPOUNDS, METHODS FOR PRODUCING SAME, AND USES THEREOF | UNIVERSITE DE REIMS CHAMPAGNE ARDENNE (FR) | 2020-01-30 | — | — | WO | disclosed |
| US-20170312363-A1 | MULTIFUNCTIONALIZED POLYETHYLENE GLYCOL DERIVATIVE AND PREPARATION METHOD THEREFOR | XIAMEN SINOPEG BIOTECH CO., LTD. (CN) | 2017-11-02 | — | — | US | disclosed |
| US-9593204-B2 | Branched polymeric emulsifiers | LUBRIZOL ADVANCED MATERIALS, INC. (US) | 2017-03-14 | — | — | US | disclosed |
| US-20170049765-A1 | Methylphenidate-Prodrugs, Processes of Making and Using the Same | COMMAVE THERAPEUTICS SA (CH) | 2017-02-23 | — | — | US | disclosed |
| US-9453037-B2 | Methylphenidate-prodrugs, processes of making and using the same | KEMPHARM, INC (US) | 2016-09-27 | — | — | US | disclosed |
| US-20150266911-A1 | Methylphenidate-Prodrugs, Processes of Making and Using the Same | COMMAVE THERAPEUTICS SA (CH) | 2015-09-24 | — | — | US | disclosed |
| US-9079928-B2 | Methylphenidate-oxoacid conjugates, processes of making and using the same | KEMPHARM, INC. (US) | 2015-07-14 | — | — | US | disclosed |
| US-20140243291-A1 | METHYLPHENIDATE-OXOACID CONJUGATES, PROCESSES OF MAKING AND USING THE SAME | COMMAVE THERAPEUTICS SA (CH) | 2014-08-28 | — | — | US | disclosed |
| US-8211850-B2 | Polyglyceryl compounds and compositions | JOHNSON & JOHNSON CONSUMER COMPANIES, INC. (US) | 2012-07-03 | — | — | US | disclosed |
| US-20120123104-A1 | POLYGLYCERYL COMPOUNDS AND COMPOSITIONS | KENVUE BRANDS LLC | 2012-05-17 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120123104-A1 | POLYGLYCERYL COMPOUNDS AND COMPOSITIONS | PHOSPHO1, SGMS1, SGMS2 | MAPK1 2727/4885 |
| US-20140243291-A1 | METHYLPHENIDATE-OXOACID CONJUGATES, PROCESSES OF MAKING AND USING THE SAME | COMT, PNMT, SLC6A3 | MAPK1 2426/4885 |
| US-20170049765-A1 | Methylphenidate-Prodrugs, Processes of Making and Using the Same | COMT, TPMT, PNMT | MAPK1 2306/4885 |
| US-20150266911-A1 | Methylphenidate-Prodrugs, Processes of Making and Using the Same | COMT, TPMT, PNMT | MAPK1 2306/4885 |
| US-20170312363-A1 | MULTIFUNCTIONALIZED POLYETHYLENE GLYCOL DERIVATIVE AND PREPARATION METHOD THEREFOR | HDGF, F11, F12 | MAPK1 1476/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.